Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GLTO
stocks logo

GLTO

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2024Q2
FY2024Q3
FY2024Q4
--
--
-2.750
-73.17%
--
--
-3.700
-25.81%
--
--
-2.820
-40.79%
Estimates Revision
The market is revising No Change the revenue expectations for Galecto, Inc. (GLTO) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 660.47%.
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+660.47%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Galecto Inc (GLTO.O) is -1.17, compared to its 5-year average forward P/E of -1.18. For a more detailed relative valuation and DCF analysis to assess Galecto Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.18
Current PE
-1.17
Overvalued PE
0.03
Undervalued PE
-2.39

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.16
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.65
Undervalued EV/EBITDA
-1.98

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
9.94
Current PS
0.00
Overvalued PS
36.95
Undervalued PS
-17.07
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

GLTO News & Events

Events Timeline

(ET)
2025-12-01
07:20:00
Guggenheim Initiates Buy Rating on Galecto (GLTO) with $32 Price Target
select
2025-12-01
05:28:00
Guggenheim Initiates Buy Rating on Galecto with $32 Price Target
select
2025-11-10 (ET)
2025-11-10
07:43:57
Galecto Finalizes Purchase of Damora Therapeutics
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
12-01Benzinga
Guggenheim Begins Coverage of Galecto with a Buy Rating and Sets Price Target at $32

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Stories: The platform provides unique stories generated by Benzinga reporters, enhancing the trading experience for its users.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing insights and strategies.

  • Market Winning Tools: Benzinga Pro equips traders with tools and information to improve their chances of success in the stock market.

[object Object]
Preview
9.5
11-11Benzinga
Rocket Lab Shares Surge Over 9%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Rocket Lab Financial Results: Rocket Lab Corp reported third-quarter revenue of $155.05 million, surpassing estimates, and a loss of three cents per share, which was better than the expected loss of 11 cents. The company's shares rose 9.3% in pre-market trading.

  • Fourth-Quarter Expectations: The company anticipates fourth-quarter revenue between $170 million and $180 million, slightly below estimates, and expects an adjusted EBITDA loss of $23 million to $29 million.

  • Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with MSP Recovery Inc gaining 81% and Hitek Global Inc dropping 34.9% after previous fluctuations.

  • Other Notable Stocks: Companies like Kaltura Inc and RealReal Inc reported better-than-expected financial results, leading to notable gains in their stock prices, while others like Outset Medical Inc and Vor Biopharma Inc faced declines due to disappointing earnings or stock offerings.

[object Object]
Preview
4.5
11-11TipRanks
Monday's Major Stock Market Highlights: Morning News Summary!

  • Market Overview: The trading week begins with a focus on significant stock market topics as reported by TipRanks.

  • Top Stories: TipRanks provides a breakdown of the biggest market happenings for investors to consider today.

  • Resource Availability: Additional top stock market stories can be found on the TipRanks platform for those interested in further insights.

  • Disclaimer: The article includes a disclaimer and an invitation to report any issues related to the content.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Galecto Inc (GLTO) stock price today?

The current price of GLTO is 22.89 USD — it has increased 3.39 % in the last trading day.

arrow icon

What is Galecto Inc (GLTO)'s business?

Galecto, Inc. is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company’s pipeline consists of small molecule drug candidates that target cancer and fibrosis signaling pathways, including a preclinical dual inhibitor of ENL-YEATS and FLT3 (GB3226) for multiple genetic subsets of AML; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications and (an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis. It is developing GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 for multiple molecularly defined subsets of acute myeloid leukemia (AML). The Company’s pipeline is GB1211, its oral small molecule galectin-3 inhibitor candidate, which is in development for the treatment of non-small cell lung cancer (NSCLC), melanoma, head and neck squamous cell carcinoma (HNSCC), and decompensated cirrhosis.

arrow icon

What is the price predicton of GLTO Stock?

Wall Street analysts forecast GLTO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GLTO is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Galecto Inc (GLTO)'s revenue for the last quarter?

Galecto Inc revenue for the last quarter amounts to -3.16M USD, decreased -17.81 % YoY.

arrow icon

What is Galecto Inc (GLTO)'s earnings per share (EPS) for the last quarter?

Galecto Inc. EPS for the last quarter amounts to -2616000.00 USD, decreased -28.35 % YoY.

arrow icon

What changes have occurred in the market's expectations for Galecto Inc (GLTO)'s fundamentals?

The market is revising No Change the revenue expectations for Galecto, Inc. (GLTO) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 660.47%.
arrow icon

How many employees does Galecto Inc (GLTO). have?

Galecto Inc (GLTO) has 5 emplpoyees as of December 05 2025.

arrow icon

What is Galecto Inc (GLTO) market cap?

Today GLTO has the market capitalization of 36.59M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free